Shalini Tripathi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shalini Tripathi has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
Mala Kumar
Department of Pediatrics, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India
28 shared publicationsS.N. Singh
Department of Pediatrics, King George's Medical University, Lucknow, Uttar Pradesh, 226003, India
11 shared publications- Mala Kumar
Department of Pediatrics, King George’s Medical University, Lucknow, Uttar Pradesh, India
9 shared publications Smrati Jain
Pediatrics, King George’s Medical University, Lucknow, Uttar Pradesh, India
4 shared publications- Ankit Pachauri
Department of Pediatrics, King George’s Medical University, Lucknow, Uttar Pradesh, India
3 shared publications S N Singh
Pediatrics, King George’s Medical University, Lucknow, Uttar Pradesh, India
3 shared publications
Latest Publications
- 21 August 2026
- Published by SAGE Publications in Journal of Neonatology
- Vol. 40 (5) , 479-493
National Neonatology Forum Clinical Decision-making for Infants Born at the Margin of Viability: A Modified Delphi Consensus Statement
Infants born at the margins of viability represent a gestational-age window characterized by uncertain survival and a high risk of mortality and long-term neurodevelopmental impairment. Evidence to guide management in low- and middle-income countries remains limited, and in India, decision-making is further influenced by heterogeneity in neonatal intensive care infrastructure, availability of trained personnel, access to perinatal services, and socio-economic and cultural disparities. Recognizing these challenges, an expert panel convened under the aegis of the National Neonatology Forum developed consensus-based guidance for clinical decision-making in periviable infants. A structured modified Delphi process was employed to achieve agreement across key domains. The panel reached consensus on 41 statements addressing 11 prioritized clinical questions relevant to periviable care in the Indian context. These recommendations provide an evidence-informed and ethically grounded framework to support clinicians and families in complex decision-making at the limits of viability. The consensus reflects current expert agreement and may evolve with emerging evidence and future research.
- 21 August 2026
- Published by SAGE Publications in Journal of Neonatology
- Vol. 40 (5) , 479-493
National Neonatology Forum Clinical Decision-making for Infants Born at the Margin of Viability: A Modified Delphi Consensus Statement
Infants born at the margins of viability represent a gestational-age window characterized by uncertain survival and a high risk of mortality and long-term neurodevelopmental impairment. Evidence to guide management in low- and middle-income countries remains limited, and in India, decision-making is further influenced by heterogeneity in neonatal intensive care infrastructure, availability of trained personnel, access to perinatal services, and socio-economic and cultural disparities. Recognizing these challenges, an expert panel convened under the aegis of the National Neonatology Forum developed consensus-based guidance for clinical decision-making in periviable infants. A structured modified Delphi process was employed to achieve agreement across key domains. The panel reached consensus on 41 statements addressing 11 prioritized clinical questions relevant to periviable care in the Indian context. These recommendations provide an evidence-informed and ethically grounded framework to support clinicians and families in complex decision-making at the limits of viability. The consensus reflects current expert agreement and may evolve with emerging evidence and future research.
- Open Access
- 11 August 2026
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 53
Trends of congenital rubella syndrome among infants (0–11 months old) in India: a multicentre hospital-based sentinel surveillance (2016–2025)
- 11 August 2026
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 53
Open AccessTrends of congenital rubella syndrome among infants (0–11 months old) in India: a multicentre hospital-based sentinel surveillance (2016–2025)
- 27 May 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (5) , e271409
Disseminated histoplasmosis in an immunocompetent infant: an uncommon diagnostic consideration
A previously asymptomatic male infant presented with persistent fever for 4 weeks with progressive abdominal distension due to hepatosplenomegaly. Investigations were suggestive of bicytopenia. His fever was non-responsive to intravenous antibiotics. Blood and urine cultures were sterile. Bone marrow showed normal haematopoiesis with evidence of yeast forms of Histoplasma capsulatum inside erythroblasts. Urine was positive for histoplasma antigen. The infant responded to intravenous liposomal amphotericin B. Fever resolved, anaemia and thrombocytopenia recovered. Hence, we report this case of an infant with disseminated histoplasmosis presenting with fever, hepatosplenomegaly and bicytopenia.
- 27 May 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (5) , e271409
Disseminated histoplasmosis in an immunocompetent infant: an uncommon diagnostic consideration
A previously asymptomatic male infant presented with persistent fever for 4 weeks with progressive abdominal distension due to hepatosplenomegaly. Investigations were suggestive of bicytopenia. His fever was non-responsive to intravenous antibiotics. Blood and urine cultures were sterile. Bone marrow showed normal haematopoiesis with evidence of yeast forms of Histoplasma capsulatum inside erythroblasts. Urine was positive for histoplasma antigen. The infant responded to intravenous liposomal amphotericin B. Fever resolved, anaemia and thrombocytopenia recovered. Hence, we report this case of an infant with disseminated histoplasmosis presenting with fever, hepatosplenomegaly and bicytopenia.
- 4 May 2026
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (11) , 902-904
Neonatal Sequential Organ Failure Assessment Score (nSOFA) for Prediction of Mortality Among Preterm Neonates with Respiratory Distress Syndrome: A Prospective Observational Study
Preterm birth is a major contributor to neonatal morbidity and mortality. This study evaluated the neonatal Sequential Organ Failure Assessment (nSOFA) score for predicting mortality in preterm neonates (< 34 weeks) with respiratory distress syndrome. Among 113 neonates, median (q1, q3) nSOFA scores at 0-6 h of life were higher in non-survivors than survivors [4 (4, 6) vs 0 (0, 2); P = 0.001], with an area under the curve (AUC) of 0.80 and a cutoff of 3. Predictive performance improved at 24 ± 3 h (AUC 0.93), with higher scores in non-survivors [8 (5, 11) vs 0 (0, 2); P < 0.001] and a cutoff of 4. Neonates with composite morbidity had significantly higher nSOFA scores at both time points.
- 4 May 2026
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (11) , 902-904
Neonatal Sequential Organ Failure Assessment Score (nSOFA) for Prediction of Mortality Among Preterm Neonates with Respiratory Distress Syndrome: A Prospective Observational Study
Preterm birth is a major contributor to neonatal morbidity and mortality. This study evaluated the neonatal Sequential Organ Failure Assessment (nSOFA) score for predicting mortality in preterm neonates (< 34 weeks) with respiratory distress syndrome. Among 113 neonates, median (q1, q3) nSOFA scores at 0-6 h of life were higher in non-survivors than survivors [4 (4, 6) vs 0 (0, 2); P = 0.001], with an area under the curve (AUC) of 0.80 and a cutoff of 3. Predictive performance improved at 24 ± 3 h (AUC 0.93), with higher scores in non-survivors [8 (5, 11) vs 0 (0, 2); P < 0.001] and a cutoff of 4. Neonates with composite morbidity had significantly higher nSOFA scores at both time points.
- 31 January 2026
- Published by SAGE Publications in Journal of Neonatology
- Vol. 40 (5) , 494-497
Propionic Acidemia in a Preterm Neonate with Ambiguous Genitalia: Two Generations Affected by Five Infant Deaths
Propionic acidemia is a rare metabolic disorder caused by mutations in either the PCCB or PCCA gene, resulting in a deficiency of the propionyl-CoA carboxylase enzyme and the accumulation of its metabolites. It is a rare autosomal recessive metabolic disorder, classified as a branched-chain organic acidemia. This case report describes a 45-day-old infant with failure to thrive and ambiguous genitalia presenting with respiratory distress, lethargy, recurrent vomiting, and poor weight gain. The family history revealed consanguinity (third-degree relatives) and the death of an older sibling at 35 days of age, who also had ambiguous genitalia, low birth weight, and prematurity. Additionally, three other infants in the previous generation had died. Arterial blood gas analysis showed elevated lactate levels with high anion gap metabolic acidosis. Ketonuria and hyperammonemia were also present. Tandem mass spectrometry–gas chromatography–mass spectrometry screening was done, which revealed increased propionyl-CoA metabolites. Whole exome sequencing further confirmed the diagnosis of propionic acidemia with autosomal recessive inheritance.
- 31 January 2026
- Published by SAGE Publications in Journal of Neonatology
- Vol. 40 (5) , 494-497
Propionic Acidemia in a Preterm Neonate with Ambiguous Genitalia: Two Generations Affected by Five Infant Deaths
Propionic acidemia is a rare metabolic disorder caused by mutations in either the PCCB or PCCA gene, resulting in a deficiency of the propionyl-CoA carboxylase enzyme and the accumulation of its metabolites. It is a rare autosomal recessive metabolic disorder, classified as a branched-chain organic acidemia. This case report describes a 45-day-old infant with failure to thrive and ambiguous genitalia presenting with respiratory distress, lethargy, recurrent vomiting, and poor weight gain. The family history revealed consanguinity (third-degree relatives) and the death of an older sibling at 35 days of age, who also had ambiguous genitalia, low birth weight, and prematurity. Additionally, three other infants in the previous generation had died. Arterial blood gas analysis showed elevated lactate levels with high anion gap metabolic acidosis. Ketonuria and hyperammonemia were also present. Tandem mass spectrometry–gas chromatography–mass spectrometry screening was done, which revealed increased propionyl-CoA metabolites. Whole exome sequencing further confirmed the diagnosis of propionic acidemia with autosomal recessive inheritance.
- 17 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e267630
Glucose-6-phosphate transporter deficiency (GSD type Ib) in an infant with an ominous outcome
A male infant presented with progressive abdominal distension, diarrhoea, fever and respiratory distress. Examination revealed hepatosplenomegaly, doll-like facies, thin extremities and oral/perianal rash. His history included recurrent pneumonia. By day six, he developed severe metabolic acidosis with elevated lactate, requiring mechanical ventilation. Despite antibiotic therapy, he suffered persistent infections including sepsis, UTI and ventilator-associated pneumonia. Genetic testing confirmed glycogen storage disease type Ib (GSD-Ib), identifying a homozygous splice site variant in intron 9 of the SLC37A4 gene. This case highlights the immune dysfunction—neutropenia and neutrophil impairment—associated with GSD-Ib, contributing to increased infection susceptibility and poor response to treatment. Genetic counselling and prenatal testing were recommended.
- 17 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e267630
Glucose-6-phosphate transporter deficiency (GSD type Ib) in an infant with an ominous outcome
A male infant presented with progressive abdominal distension, diarrhoea, fever and respiratory distress. Examination revealed hepatosplenomegaly, doll-like facies, thin extremities and oral/perianal rash. His history included recurrent pneumonia. By day six, he developed severe metabolic acidosis with elevated lactate, requiring mechanical ventilation. Despite antibiotic therapy, he suffered persistent infections including sepsis, UTI and ventilator-associated pneumonia. Genetic testing confirmed glycogen storage disease type Ib (GSD-Ib), identifying a homozygous splice site variant in intron 9 of the SLC37A4 gene. This case highlights the immune dysfunction—neutropenia and neutrophil impairment—associated with GSD-Ib, contributing to increased infection susceptibility and poor response to treatment. Genetic counselling and prenatal testing were recommended.
- 9 June 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 55 (3) , 223-227
“Assessment of serum homocysteine levels in congenital heart disease and with congenital rubella infection: A hospital-based case-control study in north Indian population”
Ours study examined the association of serum homocysteine (Hcy) levels with congenital heart disease (CHD) and congenital rubella infection (CRI) suggesting a potential pathogenic interaction between metabolic dysregulation and viral teratogenicity.
- 9 June 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 55 (3) , 223-227
“Assessment of serum homocysteine levels in congenital heart disease and with congenital rubella infection: A hospital-based case-control study in north Indian population”
Ours study examined the association of serum homocysteine (Hcy) levels with congenital heart disease (CHD) and congenital rubella infection (CRI) suggesting a potential pathogenic interaction between metabolic dysregulation and viral teratogenicity.
- 11 May 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (5) , e264778
Congenital hyperinsulinemic hypoglycaemia in a neonate: a rare homozygous ABCC8 gene mutation
Hyperinsulinemic hypoglycaemia (HH) is a heterogeneous disorder causing persistent hypoketotic hypoglycaemia in neonates and infants. Congenital hyperinsulinism (CHI) is a rare cause of HH, resulting from inappropriate insulin secretion by pancreatic β-cells due to genetic defects in key genes, notably ABCC8 and KCNJ11, which encode the SUR1 and Kir6.2 components of the KATP channels, respectively. We present a case of a neonate with congenital HH with persistent hypoglycaemia since birth, which was managed with high-dose glucose infusions, diazoxide and octreotide. A homozygous pathogenic missense variant, c4253G>A (p.Arg1418His) in Exon 35 of the ABCC8 gene was identified in the neonate, confirming CHI. Despite initial refractoriness to treatment, the infant responded to octreotide therapy, cornstarch and careful management with regular feeds and monitoring, avoiding the need for surgical intervention. This case underscores the critical role of genetic diagnosis and timely management in preventing long-term neurological sequelae.
- 11 May 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (5) , e264778
Congenital hyperinsulinemic hypoglycaemia in a neonate: a rare homozygous ABCC8 gene mutation
Hyperinsulinemic hypoglycaemia (HH) is a heterogeneous disorder causing persistent hypoketotic hypoglycaemia in neonates and infants. Congenital hyperinsulinism (CHI) is a rare cause of HH, resulting from inappropriate insulin secretion by pancreatic β-cells due to genetic defects in key genes, notably ABCC8 and KCNJ11, which encode the SUR1 and Kir6.2 components of the KATP channels, respectively. We present a case of a neonate with congenital HH with persistent hypoglycaemia since birth, which was managed with high-dose glucose infusions, diazoxide and octreotide. A homozygous pathogenic missense variant, c4253G>A (p.Arg1418His) in Exon 35 of the ABCC8 gene was identified in the neonate, confirming CHI. Despite initial refractoriness to treatment, the infant responded to octreotide therapy, cornstarch and careful management with regular feeds and monitoring, avoiding the need for surgical intervention. This case underscores the critical role of genetic diagnosis and timely management in preventing long-term neurological sequelae.
- 25 April 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Seven-day versus 14-day antibiotic course for culture-proven neonatal sepsis: a multicentre randomised non-inferiority trial in a low and middle-income country
Objective: Definitive guidance regarding the duration of antibiotics for neonatal sepsis is lacking. We hypothesised that a 7-day antibiotic course is non-inferior to a 14-day course for treating culture-proven sepsis. Design: Randomised, controlled, non-inferiority trial with masked outcome assessment in eight centres in a low and middle-income country. Patients: Neonates with a birth weight (BW) ≥1000 g and blood culture-proven sepsis were randomised on day 7 of sensitive antibiotic therapy provided sepsis had clinically remitted. Exclusions: Staphylococcus aureus or fungal sepsis, and infections requiring prolonged antibiotics. We planned to enrol 350 per group, assuming 10% rate of primary outcome, +7% non-inferiority margin, one-sided 5% alpha, 90% power, 10% loss to follow-up. Intervention: 7 days (no further treatment); comparison: 14 days (7 days postrandomisation). Outcomes: Primary: relapse (definite or probable) within day 21 postantibiotic completion. Secondary outcomes: composite of mortality or definite/probable/secondary sepsis and duration of hospitalisation. One interim analysis (per protocol (PP)) was planned. Results: 126 and 135 subjects were recruited in 7-day and 14-day groups, respectively, with mean (SD) birth weight (BW) 2250.9 (741.1) and 2187.8 (718.8) g. The trial was terminated early, based on interim PP analysis. 2/125 and 6/130 subjects had the primary outcome in 7-day and 14-day groups, respectively (risk difference (RD)=−3.0% (99.5% CI −9.2%, +3.1%), below non-inferiority margin). The composite secondary outcome also favoured the 7-day regimen (RD: −3.7% (99.5% CI −12.4% to +5.1%)). Duration of hospitalisation was shorter in 7-day group (median difference: −4 days (95% CI −5 to –3)). Conclusions: A 7-day course of antibiotics may be non-inferior to a 14-day course for uncomplicated bacterial neonatal sepsis. Trial registration number: NCT03280147.
- 25 April 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Seven-day versus 14-day antibiotic course for culture-proven neonatal sepsis: a multicentre randomised non-inferiority trial in a low and middle-income country
Objective: Definitive guidance regarding the duration of antibiotics for neonatal sepsis is lacking. We hypothesised that a 7-day antibiotic course is non-inferior to a 14-day course for treating culture-proven sepsis. Design: Randomised, controlled, non-inferiority trial with masked outcome assessment in eight centres in a low and middle-income country. Patients: Neonates with a birth weight (BW) ≥1000 g and blood culture-proven sepsis were randomised on day 7 of sensitive antibiotic therapy provided sepsis had clinically remitted. Exclusions: Staphylococcus aureus or fungal sepsis, and infections requiring prolonged antibiotics. We planned to enrol 350 per group, assuming 10% rate of primary outcome, +7% non-inferiority margin, one-sided 5% alpha, 90% power, 10% loss to follow-up. Intervention: 7 days (no further treatment); comparison: 14 days (7 days postrandomisation). Outcomes: Primary: relapse (definite or probable) within day 21 postantibiotic completion. Secondary outcomes: composite of mortality or definite/probable/secondary sepsis and duration of hospitalisation. One interim analysis (per protocol (PP)) was planned. Results: 126 and 135 subjects were recruited in 7-day and 14-day groups, respectively, with mean (SD) birth weight (BW) 2250.9 (741.1) and 2187.8 (718.8) g. The trial was terminated early, based on interim PP analysis. 2/125 and 6/130 subjects had the primary outcome in 7-day and 14-day groups, respectively (risk difference (RD)=−3.0% (99.5% CI −9.2%, +3.1%), below non-inferiority margin). The composite secondary outcome also favoured the 7-day regimen (RD: −3.7% (99.5% CI −12.4% to +5.1%)). Duration of hospitalisation was shorter in 7-day group (median difference: −4 days (95% CI −5 to –3)). Conclusions: A 7-day course of antibiotics may be non-inferior to a 14-day course for uncomplicated bacterial neonatal sepsis. Trial registration number: NCT03280147.